The rapid and continuous upsurge of interesting data in the subject of tumor immunology necessitates the publication of an annual series to furnish the updated materials to the students, researchers, and clinicians in this rapidly advancing field. Concepts and methodologies are ever changing. Also, current research in tumor immunology promises to offer breakthroughs in the future. Important is the need to communicate to the right people the exact role of immunodiagnostic methods and immunologยญ ical intervention in cancer prevention and treatment. The role of immunoยญ therapy in combination with conventional modalities of treatment needs in its proper perspective. Oncogene, interferon, lymphoยญ to be understood kines, monoclonal antibodies, natural killer cells, platelet-mediated cytoยญ toxicity of antibody-coated target cells, suppressor cells, platelet-derived factors, plasma-blocking factors, control of suppressor cell function, abยญ rogation of plasma-blocking factors, etc. , are some of the areas that are continually advancing. Progress in these areas will have implication in cancer therapy. Further, it is already understood that if immunocompeยญ tence of the host can be maintained at a reasonably good level, there exists the potential to increase the therapeutic indexes of conventional modalities of treatment. This series will attempt to present updated inforยญ mation in all these areas based on contributed and solicited articles. P. K
CONTENT
1 Ceils Responsible for Tumor Surveillance in Man: Effects of Radiotherapy, Chemotherapy, and Biologic Response Modifiers -- 2 Immunity and Its Role in Conventional Cancer Therapy -- 3 Immunologic Methods of Diagnostic and Prognostic Value in Tumor Bearers -- 4 Complement and Cancer: Activation of the Alternative Pathway as a Theoretical Base for Immunotherapy -- 5 Role of Carcinoembryonic Antigen Assay in the Management of Cancer -- 6 Active Specific Immunotherapy as an Adjunct to the Treatment of Metastatic Solid Tumors: Present and Future Prospects
